Aplastic Anemia Clinical Trials in Tianjin, Tianjin Municipality
7 recruitingTianjin, Tianjin Municipality, China
Showing 1–7 of 7 trials
Recruiting
Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS
Myelodysplastic SyndromesAplastic AnemiaAutoimmune Hemolytic Anemia+1 more
Institute of Hematology & Blood Diseases Hospital, China323 enrolled1 locationNCT07578675
Recruiting
National Longitudinal Cohort of Hematological Diseases
Acute Myeloid LeukemiaMultiple MyelomaMyelodysplastic Syndrome+14 more
Institute of Hematology & Blood Diseases Hospital, China2,300 enrolled1 locationNCT04645199
Recruiting
Reproductive and Mental Health of Patients With Aplastic Anemia
Aplastic AnemiaReproductive Health
Institute of Hematology & Blood Diseases Hospital, China600 enrolled1 locationNCT06936930
Recruiting
Phase 1
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
RelapseCAR-T Cell TherapyRefractory+1 more
Institute of Hematology & Blood Diseases Hospital, China15 enrolled1 locationNCT06622694
Recruiting
Phase 2
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Aplastic AnemiaTPO Receptor Agonists
Institute of Hematology & Blood Diseases Hospital, China48 enrolled1 locationNCT06613880
Recruiting
Phase 2
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Immunosuppressive therapySevere Aplastic AnemiaCyclophosphamide Reduced-dose
Institute of Hematology & Blood Diseases Hospital, China75 enrolled1 locationNCT06695741
Recruiting
Phase 2
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Severe Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06254560